High prevalence of Parkinson's disease in the Faroe Islands

Neurology

Volumn 49, Issue 2, 1997, Pages 426-432

  Wermuth, Lene ^a   Joensen, Poul ^b   Bünger, Nick ^c   Jeune, Bernard ^d  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b National Hospital   (Faroe Islands)

^c SVENDBORG HOSPITAL   (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; NONHUMAN; PARKINSONISM; PREVALENCE; PRIORITY JOURNAL;

EID: 0030815625     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.2.426     Document Type: Article

References (45)

1. de Pedro-Cuesta J, Wermuth L, Abraira V, Stawiarz L. Levodopa use in Denmark: high levels in Greenland and the Faroe Islands. Acta Neurol Scand 1995;91:89-97.
2. de Pedro-Cuesta J, Petersen IJ, Vassilopoulos D, Micheli F, Garcia-Inesta A. Epidemiological assessment of levodopa use by populations. Acta Neurol Scand 1991;83:328-335.
3. Aquilonius S-M, Hartvig P. A Swedish county with unexpectedly high utilization of antiparkinsonian drugs. Acta Neurol Scand 1986;74:379-382.
4. de Pedro-Cuesta J, Petersen IJ, Stawiarz L, et al. High levodopa use in periodically time-clustered, Icelandic birth cohorts. A vestige of parkinsonism etiology? Acta Neurol Scand 1995;91:79-88.
5. Govoni V, Granieri E, Tola MR, et al. Prevalence of anti-Parkinson drugs' use in Ferrara, Northern Italy, 1988. Acta Neurol Scand 1994;89:433-438.
6. Menniti-Ippolito F, Spila-Alegiani S, Vanacore N, et al. Estimate of parkinsonism prevalence through drug prescription histories in the Province of Rome, Italy. Acta Neurol Scand 1995;92:49-54.
7. Tanner CM. Epidemiology of Parkinson's disease. Neurol Clin 1992;10:317-329.
8. Zhang Z-X, Roman GC. Worldwide occurrence of Parkinson's disease: an updated review. Neuroepidemiology 1993;12:195-208.
9. de Pedro-Cuesta J. Parkinson's disease occurrence in Europe. Acta Neurol Scand 1991;84:357-365.
10. Mjönes H. Paralysis agitans. Acta Psychiat Neurol Scand 1949;(suppl 54):1-195.
11. Broman T. Parkinson's syndrome, prevalence and incidence in Göteborg. Acta Neurol Scand 1963;39(suppl 4):95-101.
12. Gudmundsson KRA. A clinical survey of parkinsonism in Iceland. Acta Neurol Scand 1967;43(suppl 33):9-61.
13. Marttila RJ, Rinne UK. Epidemiology of Parkinson's disease in Finland. Acta Neurol Scand 1976;53:81-102.
14. Dupont E. Epidemiology of parkinsonism, the Parkinson investigation AArhus, Denmark. In: Worm-Petersen J, Bøttcher J, eds. Symposium on parkinsonism. Denmark: Merck, Sharp og Dohme, 1977:65-75.
15. Wermuth L. An epidemiological investigation of patients with Parkinson's disease from an outpatient clinic [in Danish]. Ugeskr Læger 1986;148:1702-1704.
16. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol 1992;32:S125-S127.
17. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992;42:1142-1146.
18. Quinn N. Parkinsonism - recognition and differential diagnosis. BMJ 1995;310:447-452.
19. Larsen JP, Dupont E, Tandberg E. Clinical diagnosis of Parkinson's disease. Proposal of diagnostic subgroups classified at different levels of confidence. Acta Neurol Scand 1994;89:242-251.
20. Sage JI, Duvoisin RC. The Parkinson plus syndromes. Curr Opin Neurol Neurosurg 1989;2:314-318.
21. Biernat HB, Wermuth L, Grandjean P. Patients suspected for mercury toxicity and Parkinson's disease tested with tremor detection system [abstract]. Mov Disord 1996;11(suppl 1):254.
22. Arbok fyri Færoyar [Yearbook of the Faroe Islands]. Skulæbokagrunnur, Færoyar: Hagfpovan [Statistical Bureau], 1996.
23. Tandberg E, Larsen JP, Nessler EG, Ruse T, Aarli JA. The epidemiology of Parkinson's disease in the County of Rogaland, Norway. Move Disord 1995;10:541-549.
24. Sutcliffe RLG, Meara JR. Parkinson's disease epidemiology in the Northampton District, England, 1992. Acta Neurol Scand 1995;92:443-450.
25. Mayeux R, Marder K, Cote LJ, et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in Northern Manhattan, 1988-1993. Am J Epidemiol 1995;142:820-827.
26. Harada H, Nishikawa S, Takahashi K. Epidemiology of Parkinson's disease in a Japanese city. Arch Neurol 1983;40:151-154.
27. Schoenberg BS, Anderson DW, Haerer AF. Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi. Neurology 1985;35:841-845.
28. Li SC, Schoenberg BS, Wang CC, et al. A prevalence survey of Parkinson's disease and other movement disorders in the People's Republic of China. Arch Neurol 1985;42:655-657.
29. Bharucha NE, Bharucha EP, Bharucha AE, Bhise AV, Schoenberg BS. Prevalence of Parkinson's disease in the Parsi community of Bombay, India. Arch Neurol 1988;45:1321-1323.
30. Tison F, Dartigues JF, Dubes L, Zuber M, Alperovitch A, Henry P. Prevalence of Parkinson's disease in the elderly: a population study in Gironde, France. Acta Neurol Scand 1994; 90:111-115.
31. Larsen JP, the Norwegian Study Group of Parkinson's Disease in the Elderly. Parkinson's disease as a community health problem: study in Norwegian nursing homes. BMJ 1991;303:741-743.
32. Wermuth L, Stenager EN, Stenager E, Boldsen J. Mortality in patients with Parkinson's disease. Acta Neurol Scand 1995; 92:55-58.
33. Rajput AH, Offord KP, Beard CM, Kurland LT. Epidemiology of parkinsonism: incidence, classification, and mortality. Ann Neurol 1984;16:278-282.
34. Marttila RJ, Rinne UK. Epidemiological approaches to the etiology of Parkinson's disease. Acta Neurol Scand 1989;126:13-18.
35. Koller W, Vetere-Overfield B, Gray C, et al. Environmental risk factors in Parkinson's disease. Neurology 1990;40:1218-1221.
36. Rajput AH. Environmental causation of Parkinson's disease Arch Neurol 1993;50:651-652.
37. de Pedro-Cuesta J, Gudmundson G, Abraica V, et al. Whooping cough and Parkinson's disease. Int J Epidemiol 1996;25:1-11.
38. Panum PL. Observations of the epidemic of measles in the Faroe Islands in 1846 [in Danish]. Bibliotek Læger 1847; R3B1:270-344.
39. Fog M, Hyllested K. Prevalence of disseminated sclerosis in the Faroes, the Orkneys and Shetland. Acta Neurol Scand 1966;42(suppl 19):9-11.
40. Joensen P. Subarachnoid hemorrhage in an isolated population. Incidence on the Faroes during the period 1962-1975 Stroke 1984;15:438-440.
41. Joensen P. Prevalence, incidence, and classification of epilepsy on the Faroes. Acta Neurol Scand 1986;74:150-155.
42. Grandjean P, Weihe P, Jørgensen PJ, Clarkson T, Cernichiari E, Viderø T. Impact of maternal seafood diet on fetal exposure to mercury, selenium, and lead. Arch Environ Health 1992;47: 185-195.
43. Olsen SF, Grandjean P, Weihe P, Viderø T. Frequency of seafood intake in pregnancy as a determinant of birth weight: evidence for a dose dependent relationship. J Epidemiol Community Health 1993;47:436-440.
44. Kurtzke JF, Hyllested K, Heltberg A. Multiple sclerosis in the Faroe Islands: transmission across four epidemics. Acta Neurol Scand 1995;91:321-325.
45. Schwartz M, Sørensen N, Brandt NJ, Høgdall E, Holm T. High incidence of cystic fibrosis on the Faroe Islands: a molecular and genealogical study. Hum Genet 1995;95:703-706.